✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Axsome Therapeutics Inc

Common Name
Axsome Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
816
Ticker
AXSM
Exchange
NASDAQ/NMS
Description
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of innovative therapies for central nervous system (CNS) disorders. The ...

Axsome Therapeutics's Financial Statements Preview

Below are the financial statements of Axsome Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenues
Product sales, net
381.68a
202.46a
50.04a
License revenue
0a
65.74a
0a
Royalty and milestone revenue
4.02a
2.41a
0a
Total revenues
385.69a
270.6a
50.04a
Operating expenses
Cost of revenue (excluding amortization and depreciation)
-33.3a
-26.07a
-5.2a
Research and development
-187.08a
-97.94a
-57.95a
Selling, general and administrative
-411.36a
-323.12a
-159.25a
Loss in fair value of contingent consideration
-28.12a
-48.92a
-3.3a
Intangible asset amortization
-6.39a
-6.38a
-4.14a
Total operating expenses
-666.26a
-502.43a
-229.84a
Loss from operations
-280.56a
-231.83a
-179.8a
Interest expense, net
-6.57a
-6.45a
-7.34a
Loss before income taxes
-287.13a
-238.28a
-187.13a
Income tax expense
-0.09a
-0.96a
0a
Net loss
-287.22a
-239.24a
-187.13a
Limited Data Preview
You are viewing a limited preview of Axsome Therapeutics’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Axsome Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Axsome Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. Axsome Therapeutics's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?